GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Choong Ang Vaccine Laboratory Co Ltd (XKRX:072020) » Definitions » 3-Year Revenue Growth Rate

Choong Ang Vaccine Laboratory Co (XKRX:072020) 3-Year Revenue Growth Rate : 5.70% (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Choong Ang Vaccine Laboratory Co 3-Year Revenue Growth Rate?

Choong Ang Vaccine Laboratory Co's Revenue per Share for the three months ended in Mar. 2024 was ₩1,175.28.

During the past 12 months, Choong Ang Vaccine Laboratory Co's average Revenue per Share Growth Rate was 10.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 5.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 5.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 3.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Choong Ang Vaccine Laboratory Co was 23.80% per year. The lowest was -7.60% per year. And the median was 7.15% per year.


Competitive Comparison of Choong Ang Vaccine Laboratory Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Choong Ang Vaccine Laboratory Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Choong Ang Vaccine Laboratory Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Choong Ang Vaccine Laboratory Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Choong Ang Vaccine Laboratory Co's 3-Year Revenue Growth Rate falls into.



Choong Ang Vaccine Laboratory Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Choong Ang Vaccine Laboratory Co  (XKRX:072020) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Choong Ang Vaccine Laboratory Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Choong Ang Vaccine Laboratory Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Choong Ang Vaccine Laboratory Co (XKRX:072020) Business Description

Traded in Other Exchanges
N/A
Address
1476-37 Yongsan-dong, Yuseong-gu, Daejeon, KOR, 305-348
Choong Ang Vaccine Laboratory Co., Ltd. manufactures and markets vaccines for animals. The company specialized in vaccines for animals and is the largest one in Korea. The company has a solid financial structure.

Choong Ang Vaccine Laboratory Co (XKRX:072020) Headlines

No Headlines